Gen Digital Inc.
Gen Digital Inc. (GEN) Stock Competitors & Peer Comparison
See (GEN) competitors and their performances in Stock Market.
Peer Comparison Table: Software - Infrastructure Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GEN | $22.04 | -1.61% | 13.3B | 14.04 | $1.57 | +2.26% |
| MSFT | $407.77 | -1.18% | 3T | 24.27 | $16.80 | +0.85% |
| ORCL | $186.83 | -3.62% | 537.2B | 33.60 | $5.56 | +1.08% |
| PLTR | $136.00 | -0.65% | 312.3B | 151.11 | $0.90 | N/A |
| PANW | $215.60 | +0.91% | 146.9B | 119.12 | $1.81 | N/A |
| CRWD | $546.18 | +0.72% | 138.5B | -866.95 | -$0.63 | N/A |
| SNPS | $513.21 | -0.58% | 98.3B | 78.84 | $6.51 | N/A |
| ADBE | $240.83 | -2.16% | 97.4B | 14.04 | $17.16 | N/A |
| FTNT | $113.87 | -1.36% | 84.3B | 44.14 | $2.58 | N/A |
| NET | $186.79 | -3.48% | 66.1B | -747.76 | -$0.25 | N/A |
Stock Comparison
GEN vs MSFT Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, MSFT has a market cap of 3T. Regarding current trading prices, GEN is priced at $22.04, while MSFT trades at $407.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas MSFT's P/E ratio is 24.27. In terms of profitability, GEN's ROE is +0.40%, compared to MSFT's ROE of +0.33%. Regarding short-term risk, GEN is more volatile compared to MSFT. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check MSFT's competition here
GEN vs ORCL Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, ORCL has a market cap of 537.2B. Regarding current trading prices, GEN is priced at $22.04, while ORCL trades at $186.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas ORCL's P/E ratio is 33.60. In terms of profitability, GEN's ROE is +0.40%, compared to ORCL's ROE of +0.57%. Regarding short-term risk, GEN is less volatile compared to ORCL. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check ORCL's competition here
GEN vs PLTR Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, PLTR has a market cap of 312.3B. Regarding current trading prices, GEN is priced at $22.04, while PLTR trades at $136.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas PLTR's P/E ratio is 151.11. In terms of profitability, GEN's ROE is +0.40%, compared to PLTR's ROE of +0.32%. Regarding short-term risk, GEN is less volatile compared to PLTR. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check PLTR's competition here
GEN vs PANW Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, PANW has a market cap of 146.9B. Regarding current trading prices, GEN is priced at $22.04, while PANW trades at $215.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas PANW's P/E ratio is 119.12. In terms of profitability, GEN's ROE is +0.40%, compared to PANW's ROE of +0.15%. Regarding short-term risk, GEN is more volatile compared to PANW. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check PANW's competition here
GEN vs CRWD Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, CRWD has a market cap of 138.5B. Regarding current trading prices, GEN is priced at $22.04, while CRWD trades at $546.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas CRWD's P/E ratio is -866.95. In terms of profitability, GEN's ROE is +0.40%, compared to CRWD's ROE of -0.05%. Regarding short-term risk, GEN is less volatile compared to CRWD. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CRWD's competition here
GEN vs SNPS Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, SNPS has a market cap of 98.3B. Regarding current trading prices, GEN is priced at $22.04, while SNPS trades at $513.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas SNPS's P/E ratio is 78.84. In terms of profitability, GEN's ROE is +0.40%, compared to SNPS's ROE of +0.05%. Regarding short-term risk, GEN is more volatile compared to SNPS. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check SNPS's competition here
GEN vs ADBE Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, ADBE has a market cap of 97.4B. Regarding current trading prices, GEN is priced at $22.04, while ADBE trades at $240.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas ADBE's P/E ratio is 14.04. In terms of profitability, GEN's ROE is +0.40%, compared to ADBE's ROE of +0.62%. Regarding short-term risk, GEN is less volatile compared to ADBE. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check ADBE's competition here
GEN vs FTNT Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, FTNT has a market cap of 84.3B. Regarding current trading prices, GEN is priced at $22.04, while FTNT trades at $113.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas FTNT's P/E ratio is 44.14. In terms of profitability, GEN's ROE is +0.40%, compared to FTNT's ROE of +1.56%. Regarding short-term risk, GEN is more volatile compared to FTNT. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check FTNT's competition here
GEN vs NET Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, NET has a market cap of 66.1B. Regarding current trading prices, GEN is priced at $22.04, while NET trades at $186.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas NET's P/E ratio is -747.76. In terms of profitability, GEN's ROE is +0.40%, compared to NET's ROE of -0.06%. Regarding short-term risk, GEN is less volatile compared to NET. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check NET's competition here
GEN vs VMW Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, VMW has a market cap of 61.5B. Regarding current trading prices, GEN is priced at $22.04, while VMW trades at $142.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas VMW's P/E ratio is 42.92. In terms of profitability, GEN's ROE is +0.40%, compared to VMW's ROE of +3.99%. Regarding short-term risk, GEN is more volatile compared to VMW. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check VMW's competition here
GEN vs CRWV Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, CRWV has a market cap of 56.9B. Regarding current trading prices, GEN is priced at $22.04, while CRWV trades at $107.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas CRWV's P/E ratio is -39.61. In terms of profitability, GEN's ROE is +0.40%, compared to CRWV's ROE of -0.40%. Regarding short-term risk, GEN is less volatile compared to CRWV. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CRWV's competition here
GEN vs SQ Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, SQ has a market cap of 51.7B. Regarding current trading prices, GEN is priced at $22.04, while SQ trades at $83.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas SQ's P/E ratio is 49.98. In terms of profitability, GEN's ROE is +0.40%, compared to SQ's ROE of -0.02%. Regarding short-term risk, GEN is more volatile compared to SQ. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check SQ's competition here
GEN vs XYZ Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, XYZ has a market cap of 42.9B. Regarding current trading prices, GEN is priced at $22.04, while XYZ trades at $72.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas XYZ's P/E ratio is 56.37. In terms of profitability, GEN's ROE is +0.40%, compared to XYZ's ROE of +0.04%. Regarding short-term risk, GEN is more volatile compared to XYZ. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check XYZ's competition here
GEN vs NETE Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, NETE has a market cap of 27.8B. Regarding current trading prices, GEN is priced at $22.04, while NETE trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas NETE's P/E ratio is N/A. In terms of profitability, GEN's ROE is +0.40%, compared to NETE's ROE of +3.34%. Regarding short-term risk, GEN is less volatile compared to NETE. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check NETE's competition here
GEN vs SPLK Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, SPLK has a market cap of 26.4B. Regarding current trading prices, GEN is priced at $22.04, while SPLK trades at $156.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas SPLK's P/E ratio is 103.22. In terms of profitability, GEN's ROE is +0.40%, compared to SPLK's ROE of +0.84%. Regarding short-term risk, GEN is more volatile compared to SPLK. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check SPLK's competition here
GEN vs VRSN Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, VRSN has a market cap of 26B. Regarding current trading prices, GEN is priced at $22.04, while VRSN trades at $285.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas VRSN's P/E ratio is 31.58. In terms of profitability, GEN's ROE is +0.40%, compared to VRSN's ROE of -0.40%. Regarding short-term risk, GEN is more volatile compared to VRSN. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check VRSN's competition here
GEN vs MDB Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, MDB has a market cap of 24.8B. Regarding current trading prices, GEN is priced at $22.04, while MDB trades at $308.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas MDB's P/E ratio is -350.82. In terms of profitability, GEN's ROE is +0.40%, compared to MDB's ROE of -0.02%. Regarding short-term risk, GEN is less volatile compared to MDB. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check MDB's competition here
GEN vs ZS Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, ZS has a market cap of 23.5B. Regarding current trading prices, GEN is priced at $22.04, while ZS trades at $146.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas ZS's P/E ratio is -339.93. In terms of profitability, GEN's ROE is +0.40%, compared to ZS's ROE of -0.03%. Regarding short-term risk, GEN is less volatile compared to ZS. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check ZS's competition here
GEN vs CPAY Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, CPAY has a market cap of 22.4B. Regarding current trading prices, GEN is priced at $22.04, while CPAY trades at $338.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas CPAY's P/E ratio is 20.29. In terms of profitability, GEN's ROE is +0.40%, compared to CPAY's ROE of +0.31%. Regarding short-term risk, GEN is more volatile compared to CPAY. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check CPAY's competition here
GEN vs AKAM Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, AKAM has a market cap of 22B. Regarding current trading prices, GEN is priced at $22.04, while AKAM trades at $149.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas AKAM's P/E ratio is 50.70. In terms of profitability, GEN's ROE is +0.40%, compared to AKAM's ROE of +0.09%. Regarding short-term risk, GEN is less volatile compared to AKAM. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check AKAM's competition here
GEN vs AFRM Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, AFRM has a market cap of 21.9B. Regarding current trading prices, GEN is priced at $22.04, while AFRM trades at $65.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas AFRM's P/E ratio is 59.46. In terms of profitability, GEN's ROE is +0.40%, compared to AFRM's ROE of +0.11%. Regarding short-term risk, GEN is less volatile compared to AFRM. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check AFRM's competition here
GEN vs FLT Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, FLT has a market cap of 21.8B. Regarding current trading prices, GEN is priced at $22.04, while FLT trades at $303.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas FLT's P/E ratio is 22.97. In terms of profitability, GEN's ROE is +0.40%, compared to FLT's ROE of +0.31%. Regarding short-term risk, GEN is more volatile compared to FLT. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check FLT's competition here
GEN vs CYBR Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, CYBR has a market cap of 20.6B. Regarding current trading prices, GEN is priced at $22.04, while CYBR trades at $408.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas CYBR's P/E ratio is -139.06. In terms of profitability, GEN's ROE is +0.40%, compared to CYBR's ROE of -0.06%. Regarding short-term risk, GEN is more volatile compared to CYBR. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check CYBR's competition here
GEN vs FFIV Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, FFIV has a market cap of 20B. Regarding current trading prices, GEN is priced at $22.04, while FFIV trades at $354.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas FFIV's P/E ratio is 29.14. In terms of profitability, GEN's ROE is +0.40%, compared to FFIV's ROE of +0.20%. Regarding short-term risk, GEN is more volatile compared to FFIV. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check FFIV's competition here
GEN vs KSPI Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, KSPI has a market cap of 16.4B. Regarding current trading prices, GEN is priced at $22.04, while KSPI trades at $86.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas KSPI's P/E ratio is 7.18. In terms of profitability, GEN's ROE is +0.40%, compared to KSPI's ROE of +0.45%. Regarding short-term risk, GEN is less volatile compared to KSPI. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check KSPI's competition here
GEN vs DOCN Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, DOCN has a market cap of 16.3B. Regarding current trading prices, GEN is priced at $22.04, while DOCN trades at $155.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas DOCN's P/E ratio is 68.29. In terms of profitability, GEN's ROE is +0.40%, compared to DOCN's ROE of +1.54%. Regarding short-term risk, GEN is less volatile compared to DOCN. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check DOCN's competition here
GEN vs IOT Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, IOT has a market cap of 16.1B. Regarding current trading prices, GEN is priced at $22.04, while IOT trades at $28.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas IOT's P/E ratio is -1405.25. In terms of profitability, GEN's ROE is +0.40%, compared to IOT's ROE of -0.01%. Regarding short-term risk, GEN is less volatile compared to IOT. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check IOT's competition here
GEN vs NLOK Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, NLOK has a market cap of 14.3B. Regarding current trading prices, GEN is priced at $22.04, while NLOK trades at $21.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas NLOK's P/E ratio is 15.15. In terms of profitability, GEN's ROE is +0.40%, compared to NLOK's ROE of +0.40%. Regarding short-term risk, GEN is less volatile compared to NLOK. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check NLOK's competition here
GEN vs PAYP Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, PAYP has a market cap of 13.6B. Regarding current trading prices, GEN is priced at $22.04, while PAYP trades at $20.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas PAYP's P/E ratio is 17.84. In terms of profitability, GEN's ROE is +0.40%, compared to PAYP's ROE of +0.58%. Regarding short-term risk, GEN is less volatile compared to PAYP. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check PAYP's competition here
GEN vs TOST Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, TOST has a market cap of 13.5B. Regarding current trading prices, GEN is priced at $22.04, while TOST trades at $23.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas TOST's P/E ratio is 34.71. In terms of profitability, GEN's ROE is +0.40%, compared to TOST's ROE of +0.21%. Regarding short-term risk, GEN is less volatile compared to TOST. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check TOST's competition here
GEN vs OKTA Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, OKTA has a market cap of 13.4B. Regarding current trading prices, GEN is priced at $22.04, while OKTA trades at $79.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas OKTA's P/E ratio is 60.35. In terms of profitability, GEN's ROE is +0.40%, compared to OKTA's ROE of +0.03%. Regarding short-term risk, GEN is less volatile compared to OKTA. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check OKTA's competition here
GEN vs RBRK Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, RBRK has a market cap of 12.2B. Regarding current trading prices, GEN is priced at $22.04, while RBRK trades at $60.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas RBRK's P/E ratio is -33.98. In terms of profitability, GEN's ROE is +0.40%, compared to RBRK's ROE of +0.64%. Regarding short-term risk, GEN is less volatile compared to RBRK. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check RBRK's competition here
GEN vs CHKP Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, CHKP has a market cap of 12.1B. Regarding current trading prices, GEN is priced at $22.04, while CHKP trades at $116.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas CHKP's P/E ratio is 11.97. In terms of profitability, GEN's ROE is +0.40%, compared to CHKP's ROE of +0.36%. Regarding short-term risk, GEN is more volatile compared to CHKP. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check CHKP's competition here
GEN vs NTNX Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, NTNX has a market cap of 11.8B. Regarding current trading prices, GEN is priced at $22.04, while NTNX trades at $44.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas NTNX's P/E ratio is 48.26. In terms of profitability, GEN's ROE is +0.40%, compared to NTNX's ROE of -0.37%. Regarding short-term risk, GEN is less volatile compared to NTNX. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check NTNX's competition here
GEN vs GDDY Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, GDDY has a market cap of 11.5B. Regarding current trading prices, GEN is priced at $22.04, while GDDY trades at $87.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas GDDY's P/E ratio is 13.79. In terms of profitability, GEN's ROE is +0.40%, compared to GDDY's ROE of +3.67%. Regarding short-term risk, GEN is less volatile compared to GDDY. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check GDDY's competition here
GEN vs CFLT Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, CFLT has a market cap of 11.1B. Regarding current trading prices, GEN is priced at $22.04, while CFLT trades at $30.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas CFLT's P/E ratio is -36.03. In terms of profitability, GEN's ROE is +0.40%, compared to CFLT's ROE of -0.27%. Regarding short-term risk, GEN is more volatile compared to CFLT. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check CFLT's competition here
GEN vs ALTR Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, ALTR has a market cap of 9.6B. Regarding current trading prices, GEN is priced at $22.04, while ALTR trades at $111.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas ALTR's P/E ratio is 699.06. In terms of profitability, GEN's ROE is +0.40%, compared to ALTR's ROE of +0.02%. Regarding short-term risk, GEN is more volatile compared to ALTR. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check ALTR's competition here
GEN vs PLAN Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, PLAN has a market cap of 9.6B. Regarding current trading prices, GEN is priced at $22.04, while PLAN trades at $63.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas PLAN's P/E ratio is -44.82. In terms of profitability, GEN's ROE is +0.40%, compared to PLAN's ROE of -0.78%. Regarding short-term risk, GEN is more volatile compared to PLAN. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check PLAN's competition here
GEN vs INFA Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, INFA has a market cap of 7.5B. Regarding current trading prices, GEN is priced at $22.04, while INFA trades at $24.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas INFA's P/E ratio is 826.33. In terms of profitability, GEN's ROE is +0.40%, compared to INFA's ROE of +0.00%. Regarding short-term risk, GEN is more volatile compared to INFA. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check INFA's competition here
GEN vs CORZ Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, CORZ has a market cap of 7.2B. Regarding current trading prices, GEN is priced at $22.04, while CORZ trades at $22.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas CORZ's P/E ratio is -6.78. In terms of profitability, GEN's ROE is +0.40%, compared to CORZ's ROE of +1.09%. Regarding short-term risk, GEN is less volatile compared to CORZ. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CORZ's competition here
GEN vs CORZZ Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, CORZZ has a market cap of 7.2B. Regarding current trading prices, GEN is priced at $22.04, while CORZZ trades at $22.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas CORZZ's P/E ratio is N/A. In terms of profitability, GEN's ROE is +0.40%, compared to CORZZ's ROE of +1.09%. Regarding short-term risk, GEN is less volatile compared to CORZZ. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CORZZ's competition here
GEN vs HCP Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, HCP has a market cap of 7.1B. Regarding current trading prices, GEN is priced at $22.04, while HCP trades at $34.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas HCP's P/E ratio is -57.97. In terms of profitability, GEN's ROE is +0.40%, compared to HCP's ROE of -0.16%. Regarding short-term risk, GEN is more volatile compared to HCP. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check HCP's competition here
GEN vs JCOM Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, JCOM has a market cap of 6.8B. Regarding current trading prices, GEN is priced at $22.04, while JCOM trades at $142.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas JCOM's P/E ratio is N/A. In terms of profitability, GEN's ROE is +0.40%, compared to JCOM's ROE of +0.06%. Regarding short-term risk, GEN is less volatile compared to JCOM. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check JCOM's competition here
GEN vs DOX Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, DOX has a market cap of 6.7B. Regarding current trading prices, GEN is priced at $22.04, while DOX trades at $62.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas DOX's P/E ratio is 12.06. In terms of profitability, GEN's ROE is +0.40%, compared to DOX's ROE of +0.17%. Regarding short-term risk, GEN is more volatile compared to DOX. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check DOX's competition here
GEN vs DBX Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, DBX has a market cap of 6.6B. Regarding current trading prices, GEN is priced at $22.04, while DBX trades at $25.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas DBX's P/E ratio is 14.10. In terms of profitability, GEN's ROE is +0.40%, compared to DBX's ROE of -0.28%. Regarding short-term risk, GEN is less volatile compared to DBX. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check DBX's competition here
GEN vs SAIL Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, SAIL has a market cap of 6.5B. Regarding current trading prices, GEN is priced at $22.04, while SAIL trades at $11.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas SAIL's P/E ratio is -21.50. In terms of profitability, GEN's ROE is +0.40%, compared to SAIL's ROE of -0.04%. Regarding short-term risk, GEN is less volatile compared to SAIL. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check SAIL's competition here
GEN vs SQSP Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, SQSP has a market cap of 6.5B. Regarding current trading prices, GEN is priced at $22.04, while SQSP trades at $46.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas SQSP's P/E ratio is -1164.25. In terms of profitability, GEN's ROE is +0.40%, compared to SQSP's ROE of +0.03%. Regarding short-term risk, GEN is more volatile compared to SQSP. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check SQSP's competition here
GEN vs BLSH Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, BLSH has a market cap of 6.4B. Regarding current trading prices, GEN is priced at $22.04, while BLSH trades at $42.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas BLSH's P/E ratio is -7.15. In terms of profitability, GEN's ROE is +0.40%, compared to BLSH's ROE of -0.26%. Regarding short-term risk, GEN is less volatile compared to BLSH. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check BLSH's competition here
GEN vs NEWR Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, NEWR has a market cap of 6.2B. Regarding current trading prices, GEN is priced at $22.04, while NEWR trades at $86.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas NEWR's P/E ratio is -41.62. In terms of profitability, GEN's ROE is +0.40%, compared to NEWR's ROE of -0.54%. Regarding short-term risk, GEN is more volatile compared to NEWR. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check NEWR's competition here
GEN vs CCCS Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, CCCS has a market cap of 5.6B. Regarding current trading prices, GEN is priced at $22.04, while CCCS trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas CCCS's P/E ratio is -875.00. In terms of profitability, GEN's ROE is +0.40%, compared to CCCS's ROE of +0.02%. Regarding short-term risk, GEN is less volatile compared to CCCS. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CCCS's competition here
GEN vs PATH Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, PATH has a market cap of 5.4B. Regarding current trading prices, GEN is priced at $22.04, while PATH trades at $10.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas PATH's P/E ratio is 19.24. In terms of profitability, GEN's ROE is +0.40%, compared to PATH's ROE of +0.15%. Regarding short-term risk, GEN is less volatile compared to PATH. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check PATH's competition here
GEN vs KLAR Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, KLAR has a market cap of 5.3B. Regarding current trading prices, GEN is priced at $22.04, while KLAR trades at $14.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas KLAR's P/E ratio is -17.89. In terms of profitability, GEN's ROE is +0.40%, compared to KLAR's ROE of -0.12%. Regarding short-term risk, GEN is less volatile compared to KLAR. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check KLAR's competition here
GEN vs S Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, S has a market cap of 5.3B. Regarding current trading prices, GEN is priced at $22.04, while S trades at $15.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas S's P/E ratio is -11.49. In terms of profitability, GEN's ROE is +0.40%, compared to S's ROE of -0.30%. Regarding short-term risk, GEN is less volatile compared to S. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check S's competition here
GEN vs CORZW Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, CORZW has a market cap of 5.1B. Regarding current trading prices, GEN is priced at $22.04, while CORZW trades at $16.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas CORZW's P/E ratio is N/A. In terms of profitability, GEN's ROE is +0.40%, compared to CORZW's ROE of +1.09%. Regarding short-term risk, GEN is less volatile compared to CORZW. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CORZW's competition here
GEN vs RELY Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, RELY has a market cap of 5B. Regarding current trading prices, GEN is priced at $22.04, while RELY trades at $23.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas RELY's P/E ratio is 49.71. In terms of profitability, GEN's ROE is +0.40%, compared to RELY's ROE of +0.13%. Regarding short-term risk, GEN is less volatile compared to RELY. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check RELY's competition here
GEN vs NVEI Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, NVEI has a market cap of 4.8B. Regarding current trading prices, GEN is priced at $22.04, while NVEI trades at $33.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas NVEI's P/E ratio is 212.44. In terms of profitability, GEN's ROE is +0.40%, compared to NVEI's ROE of -0.00%. Regarding short-term risk, GEN is more volatile compared to NVEI. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check NVEI's competition here
GEN vs WEX Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, WEX has a market cap of 4.7B. Regarding current trading prices, GEN is priced at $22.04, while WEX trades at $135.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas WEX's P/E ratio is 15.28. In terms of profitability, GEN's ROE is +0.40%, compared to WEX's ROE of +0.27%. Regarding short-term risk, GEN is less volatile compared to WEX. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check WEX's competition here
GEN vs KVYO Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, KVYO has a market cap of 4.4B. Regarding current trading prices, GEN is priced at $22.04, while KVYO trades at $14.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas KVYO's P/E ratio is -481.33. In terms of profitability, GEN's ROE is +0.40%, compared to KVYO's ROE of -0.01%. Regarding short-term risk, GEN is less volatile compared to KVYO. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check KVYO's competition here
GEN vs ACIW Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, ACIW has a market cap of 4.3B. Regarding current trading prices, GEN is priced at $22.04, while ACIW trades at $42.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas ACIW's P/E ratio is 21.30. In terms of profitability, GEN's ROE is +0.40%, compared to ACIW's ROE of +0.14%. Regarding short-term risk, GEN is less volatile compared to ACIW. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check ACIW's competition here
GEN vs WIX Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, WIX has a market cap of 4.2B. Regarding current trading prices, GEN is priced at $22.04, while WIX trades at $75.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas WIX's P/E ratio is 86.31. In terms of profitability, GEN's ROE is +0.40%, compared to WIX's ROE of -0.22%. Regarding short-term risk, GEN is less volatile compared to WIX. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check WIX's competition here
GEN vs ESMT Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, ESMT has a market cap of 3.9B. Regarding current trading prices, GEN is priced at $22.04, while ESMT trades at $23.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas ESMT's P/E ratio is 153.67. In terms of profitability, GEN's ROE is +0.40%, compared to ESMT's ROE of +0.03%. Regarding short-term risk, GEN is more volatile compared to ESMT. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check ESMT's competition here
GEN vs FOUR Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, FOUR has a market cap of 3.7B. Regarding current trading prices, GEN is priced at $22.04, while FOUR trades at $40.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas FOUR's P/E ratio is 46.89. In terms of profitability, GEN's ROE is +0.40%, compared to FOUR's ROE of +0.06%. Regarding short-term risk, GEN is less volatile compared to FOUR. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check FOUR's competition here
GEN vs DLO Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, DLO has a market cap of 3.7B. Regarding current trading prices, GEN is priced at $22.04, while DLO trades at $12.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas DLO's P/E ratio is 19.52. In terms of profitability, GEN's ROE is +0.40%, compared to DLO's ROE of +0.38%. Regarding short-term risk, GEN is less volatile compared to DLO. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check DLO's competition here
GEN vs BB Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, BB has a market cap of 3.7B. Regarding current trading prices, GEN is priced at $22.04, while BB trades at $6.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas BB's P/E ratio is 69.00. In terms of profitability, GEN's ROE is +0.40%, compared to BB's ROE of +0.07%. Regarding short-term risk, GEN is less volatile compared to BB. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check BB's competition here
GEN vs BOX Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, BOX has a market cap of 3.3B. Regarding current trading prices, GEN is priced at $22.04, while BOX trades at $24.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas BOX's P/E ratio is 41.47. In terms of profitability, GEN's ROE is +0.40%, compared to BOX's ROE of +1.16%. Regarding short-term risk, GEN is less volatile compared to BOX. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check BOX's competition here
GEN vs VRNS Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, VRNS has a market cap of 3.3B. Regarding current trading prices, GEN is priced at $22.04, while VRNS trades at $27.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas VRNS's P/E ratio is -24.64. In terms of profitability, GEN's ROE is +0.40%, compared to VRNS's ROE of -0.26%. Regarding short-term risk, GEN is less volatile compared to VRNS. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check VRNS's competition here
GEN vs SWI Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, SWI has a market cap of 3.2B. Regarding current trading prices, GEN is priced at $22.04, while SWI trades at $18.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas SWI's P/E ratio is 28.89. In terms of profitability, GEN's ROE is +0.40%, compared to SWI's ROE of +0.08%. Regarding short-term risk, GEN is more volatile compared to SWI. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check SWI's competition here
GEN vs CLBT Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, CLBT has a market cap of 3.2B. Regarding current trading prices, GEN is priced at $22.04, while CLBT trades at $12.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas CLBT's P/E ratio is 41.10. In terms of profitability, GEN's ROE is +0.40%, compared to CLBT's ROE of +0.18%. Regarding short-term risk, GEN is less volatile compared to CLBT. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CLBT's competition here
GEN vs QLYS Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, QLYS has a market cap of 3.2B. Regarding current trading prices, GEN is priced at $22.04, while QLYS trades at $90.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas QLYS's P/E ratio is 16.18. In terms of profitability, GEN's ROE is +0.40%, compared to QLYS's ROE of +0.37%. Regarding short-term risk, GEN is less volatile compared to QLYS. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check QLYS's competition here
GEN vs EVOP Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, EVOP has a market cap of 3B. Regarding current trading prices, GEN is priced at $22.04, while EVOP trades at $33.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas EVOP's P/E ratio is -309.00. In terms of profitability, GEN's ROE is +0.40%, compared to EVOP's ROE of -0.03%. Regarding short-term risk, GEN is more volatile compared to EVOP. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check EVOP's competition here
GEN vs TDC Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, TDC has a market cap of 3B. Regarding current trading prices, GEN is priced at $22.04, while TDC trades at $31.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas TDC's P/E ratio is 7.27. In terms of profitability, GEN's ROE is +0.40%, compared to TDC's ROE of +1.42%. Regarding short-term risk, GEN is less volatile compared to TDC. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check TDC's competition here
GEN vs PAGS Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, PAGS has a market cap of 2.9B. Regarding current trading prices, GEN is priced at $22.04, while PAGS trades at $9.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas PAGS's P/E ratio is 6.78. In terms of profitability, GEN's ROE is +0.40%, compared to PAGS's ROE of +0.14%. Regarding short-term risk, GEN is more volatile compared to PAGS. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check PAGS's competition here
GEN vs STNE Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, STNE has a market cap of 2.8B. Regarding current trading prices, GEN is priced at $22.04, while STNE trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas STNE's P/E ratio is 5.97. In terms of profitability, GEN's ROE is +0.40%, compared to STNE's ROE of +0.20%. Regarding short-term risk, GEN is more volatile compared to STNE. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check STNE's competition here
GEN vs NTCT Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, NTCT has a market cap of 2.8B. Regarding current trading prices, GEN is priced at $22.04, while NTCT trades at $38.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas NTCT's P/E ratio is 29.40. In terms of profitability, GEN's ROE is +0.40%, compared to NTCT's ROE of +0.06%. Regarding short-term risk, GEN is less volatile compared to NTCT. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check NTCT's competition here
GEN vs EEFT Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, EEFT has a market cap of 2.7B. Regarding current trading prices, GEN is priced at $22.04, while EEFT trades at $69.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas EEFT's P/E ratio is 10.26. In terms of profitability, GEN's ROE is +0.40%, compared to EEFT's ROE of +0.24%. Regarding short-term risk, GEN is more volatile compared to EEFT. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check EEFT's competition here
GEN vs CCC Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, CCC has a market cap of 2.6B. Regarding current trading prices, GEN is priced at $22.04, while CCC trades at $4.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas CCC's P/E ratio is 75.17. In terms of profitability, GEN's ROE is +0.40%, compared to CCC's ROE of +0.02%. Regarding short-term risk, GEN is less volatile compared to CCC. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check CCC's competition here
GEN vs WRD Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, WRD has a market cap of 2.4B. Regarding current trading prices, GEN is priced at $22.04, while WRD trades at $7.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas WRD's P/E ratio is -9.76. In terms of profitability, GEN's ROE is +0.40%, compared to WRD's ROE of -0.24%. Regarding short-term risk, GEN is less volatile compared to WRD. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check WRD's competition here
GEN vs TENB Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, TENB has a market cap of 2.3B. Regarding current trading prices, GEN is priced at $22.04, while TENB trades at $21.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas TENB's P/E ratio is -210.10. In terms of profitability, GEN's ROE is +0.40%, compared to TENB's ROE of -0.04%. Regarding short-term risk, GEN is less volatile compared to TENB. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check TENB's competition here
GEN vs CSGS Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, CSGS has a market cap of 2.3B. Regarding current trading prices, GEN is priced at $22.04, while CSGS trades at $80.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas CSGS's P/E ratio is 36.02. In terms of profitability, GEN's ROE is +0.40%, compared to CSGS's ROE of +0.22%. Regarding short-term risk, GEN is more volatile compared to CSGS. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check CSGS's competition here
GEN vs AVPT Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, AVPT has a market cap of 2.1B. Regarding current trading prices, GEN is priced at $22.04, while AVPT trades at $10.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas AVPT's P/E ratio is 50.30. In terms of profitability, GEN's ROE is +0.40%, compared to AVPT's ROE of +0.10%. Regarding short-term risk, GEN is less volatile compared to AVPT. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check AVPT's competition here
GEN vs AVDX Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, AVDX has a market cap of 2.1B. Regarding current trading prices, GEN is priced at $22.04, while AVDX trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas AVDX's P/E ratio is -250.00. In terms of profitability, GEN's ROE is +0.40%, compared to AVDX's ROE of -0.02%. Regarding short-term risk, GEN is more volatile compared to AVDX. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check AVDX's competition here
GEN vs GETVV Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, GETVV has a market cap of 2.1B. Regarding current trading prices, GEN is priced at $22.04, while GETVV trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas GETVV's P/E ratio is N/A. In terms of profitability, GEN's ROE is +0.40%, compared to GETVV's ROE of N/A. Regarding short-term risk, GEN is less volatile compared to GETVV. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check GETVV's competition here
GEN vs ATEN Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, ATEN has a market cap of 2B. Regarding current trading prices, GEN is priced at $22.04, while ATEN trades at $27.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas ATEN's P/E ratio is 44.87. In terms of profitability, GEN's ROE is +0.40%, compared to ATEN's ROE of +0.21%. Regarding short-term risk, GEN is less volatile compared to ATEN. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check ATEN's competition here
GEN vs FORG Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, FORG has a market cap of 2B. Regarding current trading prices, GEN is priced at $22.04, while FORG trades at $23.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas FORG's P/E ratio is -22.53. In terms of profitability, GEN's ROE is +0.40%, compared to FORG's ROE of -0.20%. Regarding short-term risk, GEN is less volatile compared to FORG. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check FORG's competition here
GEN vs SPSC Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, SPSC has a market cap of 1.9B. Regarding current trading prices, GEN is priced at $22.04, while SPSC trades at $51.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas SPSC's P/E ratio is 21.57. In terms of profitability, GEN's ROE is +0.40%, compared to SPSC's ROE of +0.09%. Regarding short-term risk, GEN is less volatile compared to SPSC. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check SPSC's competition here
GEN vs GSKY Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, GSKY has a market cap of 1.9B. Regarding current trading prices, GEN is priced at $22.04, while GSKY trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas GSKY's P/E ratio is 18.61. In terms of profitability, GEN's ROE is +0.40%, compared to GSKY's ROE of +5.47%. Regarding short-term risk, GEN is more volatile compared to GSKY. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check GSKY's competition here
GEN vs RAMP Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, RAMP has a market cap of 1.8B. Regarding current trading prices, GEN is priced at $22.04, while RAMP trades at $28.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas RAMP's P/E ratio is 27.56. In terms of profitability, GEN's ROE is +0.40%, compared to RAMP's ROE of +0.07%. Regarding short-term risk, GEN is less volatile compared to RAMP. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check RAMP's competition here
GEN vs EVCM Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, EVCM has a market cap of 1.8B. Regarding current trading prices, GEN is priced at $22.04, while EVCM trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas EVCM's P/E ratio is 77.77. In terms of profitability, GEN's ROE is +0.40%, compared to EVCM's ROE of +0.04%. Regarding short-term risk, GEN is less volatile compared to EVCM. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check EVCM's competition here
GEN vs GET Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, GET has a market cap of 1.8B. Regarding current trading prices, GEN is priced at $22.04, while GET trades at $1.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas GET's P/E ratio is 31.33. In terms of profitability, GEN's ROE is +0.40%, compared to GET's ROE of N/A. Regarding short-term risk, GEN is less volatile compared to GET. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check GET's competition here
GEN vs PAYO Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, PAYO has a market cap of 1.7B. Regarding current trading prices, GEN is priced at $22.04, while PAYO trades at $5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas PAYO's P/E ratio is 25.60. In terms of profitability, GEN's ROE is +0.40%, compared to PAYO's ROE of +0.10%. Regarding short-term risk, GEN is more volatile compared to PAYO. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check PAYO's competition here
GEN vs MQ Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, MQ has a market cap of 1.7B. Regarding current trading prices, GEN is priced at $22.04, while MQ trades at $3.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas MQ's P/E ratio is 399.00. In terms of profitability, GEN's ROE is +0.40%, compared to MQ's ROE of +0.00%. Regarding short-term risk, GEN is less volatile compared to MQ. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check MQ's competition here
GEN vs STER Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, STER has a market cap of 1.6B. Regarding current trading prices, GEN is priced at $22.04, while STER trades at $16.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas STER's P/E ratio is -98.47. In terms of profitability, GEN's ROE is +0.40%, compared to STER's ROE of -0.00%. Regarding short-term risk, GEN is more volatile compared to STER. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check STER's competition here
GEN vs FIVN Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, FIVN has a market cap of 1.6B. Regarding current trading prices, GEN is priced at $22.04, while FIVN trades at $20.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas FIVN's P/E ratio is 32.20. In terms of profitability, GEN's ROE is +0.40%, compared to FIVN's ROE of +0.07%. Regarding short-term risk, GEN is less volatile compared to FIVN. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check FIVN's competition here
GEN vs PICS Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, PICS has a market cap of 1.6B. Regarding current trading prices, GEN is priced at $22.04, while PICS trades at $12.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas PICS's P/E ratio is 7.21. In terms of profitability, GEN's ROE is +0.40%, compared to PICS's ROE of +0.16%. Regarding short-term risk, GEN is less volatile compared to PICS. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check PICS's competition here
GEN vs BAND Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, BAND has a market cap of 1.6B. Regarding current trading prices, GEN is priced at $22.04, while BAND trades at $49.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas BAND's P/E ratio is -130.11. In terms of profitability, GEN's ROE is +0.40%, compared to BAND's ROE of -0.01%. Regarding short-term risk, GEN is less volatile compared to BAND. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check BAND's competition here
GEN vs RXT Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, RXT has a market cap of 1.6B. Regarding current trading prices, GEN is priced at $22.04, while RXT trades at $6.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas RXT's P/E ratio is -10.36. In terms of profitability, GEN's ROE is +0.40%, compared to RXT's ROE of +0.12%. Regarding short-term risk, GEN is less volatile compared to RXT. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check RXT's competition here
GEN vs ZUO Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, ZUO has a market cap of 1.5B. Regarding current trading prices, GEN is priced at $22.04, while ZUO trades at $10.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas ZUO's P/E ratio is -19.65. In terms of profitability, GEN's ROE is +0.40%, compared to ZUO's ROE of -0.44%. Regarding short-term risk, GEN is more volatile compared to ZUO. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check ZUO's competition here
GEN vs APPN Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, APPN has a market cap of 1.5B. Regarding current trading prices, GEN is priced at $22.04, while APPN trades at $20.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas APPN's P/E ratio is 1026.00. In terms of profitability, GEN's ROE is +0.40%, compared to APPN's ROE of -0.02%. Regarding short-term risk, GEN is less volatile compared to APPN. This indicates potentially lower risk in terms of short-term price fluctuations for GEN.Check APPN's competition here
GEN vs SUMO Comparison May 2026
GEN plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEN stands at 13.3B. In comparison, SUMO has a market cap of 1.5B. Regarding current trading prices, GEN is priced at $22.04, while SUMO trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEN currently has a P/E ratio of 14.04, whereas SUMO's P/E ratio is -11.36. In terms of profitability, GEN's ROE is +0.40%, compared to SUMO's ROE of -0.31%. Regarding short-term risk, GEN is more volatile compared to SUMO. This indicates potentially higher risk in terms of short-term price fluctuations for GEN.Check SUMO's competition here